...
首页> 外文期刊>ACS medicinal chemistry letters >Identification of N-(2-Phenoxyethyl)imidazo[1,2-a]pyridine-3-carboxamides as New Antituberculosis Agents
【24h】

Identification of N-(2-Phenoxyethyl)imidazo[1,2-a]pyridine-3-carboxamides as New Antituberculosis Agents

机译:N-(2-苯氧基乙基)咪唑并[1,2-a]吡啶-3-羧酰胺类化合物作为新型抗结核药物的鉴定

获取原文
获取原文并翻译 | 示例
           

摘要

A series of inaidazo[1,2-a]pyridine carboxamides (IPAs) bearing an N-(2-phenoxyethyl) moiety was designed and synthesized as new antitubercular agents. Seven 2,6-dimethyl IPAs demonstrated excellent in vitro activity (MIC: 0.025-0.054 mu g/mL) against the drug susceptive H37Rv strain and two clinically isolated multidrug-resistant Mycobacterium tuberculosisstrains. Compound 10j displayed acceptable safety and pharmacokinetic properties, opening a new direction for further development. KEYWORDS: Antitubercular agents., MTB H37Rv, multidrug resistant-MTB,
机译:设计并合成了一系列带有N-(2-苯氧基乙基)部分的吲哚并[1,2-a]吡啶羧酰胺(IPA),并将其合成为新的抗结核药。七个2,6-二甲基IPA表现出优异的体外活性(MIC:0.025-0.054μg / mL),对药物敏感的H37Rv菌株和两个临床分离的耐多药结核分枝杆菌菌株具有良好的体外活性。化合物10j显示出可接受的安全性和药代动力学特性,为进一步开发开辟了新的方向。关键词:抗结核药。MTB H37Rv,耐多药MTB,

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号